1. Home
  2. Conferences
  3. Biocides Europe 2025
  4. programme

Agenda

Please note: all timings are listed in CET; to view start times in your local time zone, please click here. 

  1. Coffee and registration

  2. Welcome and introduction by the moderator

    David Dillon David Dillon
    Independent Biocides Expert
  3. Session 1: Overviews

  4. European Commission overview

    • Implementation dialogue on biocides, food safety simplification omnibus, BPR evaluation
    • Derogations for sulfuryl fluoride for cultural heritage protection
    • REACH microplastics restriction – impact on biocides 
    Ligia Negulici Ligia Negulici
    Policy Officer, European Commission, DG SANTE, Unit Pesticides and Biocides

  5. ECHA overview

    • Update on active substance approval
    • Update on union authorisation (UA)
    • Evolution of ECHA IT tools for biocides
    • What is coming up from ECHA on biocides 
    Javier Sanchez Saez Javier Sanchez Saez
    Head of Unit - Biocidal Products, European Chemicals Agency

  6. Member state overview

    • Update on active substances in Austria
    • Updated guidelines
    • Ideas for improving the BPR 
    Peter Schindler Peter Schindler
    Head of Expert Team, Environment Agency Austria

  7. Industry perspective on classification of biocide active substances

    • Interplay between BPR and CLP
    • Exclusion and substitution criteria
    • Biocidal Products Committee versus Committee for Risk Assessment opinion
    • Practical and regulatory consequences
    • Case study on ethanol 
    Koen Van Maldegem Koen Van Maldegem
    Partner, EU Regulatory, Fieldfisher LLP, Belgium

  8. Q&A

  9. Refreshment break and networking

  10. Session 2: Member state competent authority (MS CA) perspectives on the latest BPR developments

  11. Upcoming renewals: Wave of active substance reassessments, impact for competent authorities

    • The competent authority experience
    • Critical issues
    • A case study 
    Raffaella Cresti Raffaella Cresti
    Senior Scientist, Ministry of Health, Italy

  12. First experiences in Denmark: What is necessary for creating successful dossiers for product and active substance renewals

    • Dossier evaluation in MS CAs
    • Moving to IUCLID: information requirements for renewal of active substances
    • Systematic improvements of BPR processes from application to authorisation 
    Johannes Lørup Buch Johannes Lørup Buch
    Toxicologist, Danish Environmental Protection Agency

  13. Connecting the dots – interplay between regulatory developments and objectives of the BPR from a German competent authority perspective

    • Interplay between different actors in the evaluation process
    • Parameters that can(not) be influenced
    • How tightening the procedures may affect the “scaffolding” of the evaluation process over time 
    Jana-Alina Zur Jana-Alina Zur
    Regulatory Officer, Federal Institute for Occupational Safety and Health (BAuA), Federal Office for Chemicals (BfC)

  14. Q&A

  15.  

    Brief intro to CHEMTREC webinar next week: International regulatory requirements for emergency response and how to comply with local requirements

    Richard Davey Richard Davey
    International Business Director, CHEMTREC

  16. Lunch and networking

  17. Session 3: Consultation for BPR revision – implementation of the current BPR and lessons for the future

  18. Taking environmental risk assessment of biocides to the next level

    • Streamlining risk assessments for the environment
    • Reducing environmental impacts through biocides
    • Simplification and environmental protection measures need to complement each other 
    Stefanie Wieck Stefanie Wieck
    Scientific Employee, German Federal Environment Agency (UBA)

  19. Value and opportunities for science in biocidal dossiers: Acceptance of realistic data in risk assessment refinements

    • Realistic data have become disruptors of the BPR process
    • Importance of realistic data to ensure useful products remain available for consumers
    • Opportunities and alignment for study protocol development or application of models
    • Examples of realistic data
    • Strengthening partnerships and collaborations between industry and authority stakeholders
    • Benefits of accelerated alignment and approval, improved efficiencies, reduced uncertainties, enhancement of scientific integrity 
    Samantha Walker Samantha Walker
    Head of Biocides & Cosmetics, Sagentia Regulatory, formerly TSG Consulting

  20. Modernizing the BPR: scientific progress and regulatory implementation

    • Implementation of the BPR and opportunities to use non-animal methods
    • Aligning the BPR with the Commission’s roadmap for phasing out animal testing 
    Tess Renahan Tess Renahan
    Adviser, PETA Science Consortium International e.V.

  21. Q&A

  22. Refreshment break and networking 

  23. Data-based economic analysis of the European biocides market, with impacts on financial market strategy

    • Biocides market at a regulatory crossroad
    • Market structure and economic trends
    • Regulatory environment and market behaviour 
    • Role of socio-economic analysis
    • REFIT — economic opportunities 
    Alex Bocquillion Alex Bocquillion
    Partner, EPPA
    Eduardo Mulas Eduardo Mulas
    Partner, EPPA

  24. Industry perspective on the REFIT

    • “REFIT” versus “revision”
    • What to take into account for the REFIT evaluation
    • Ideas for how to improve the BPR and its implementation  
    Boris Van Berlo Boris Van Berlo
    Team Lead Biocides, Biocides for Europe, Cefic

  25. The BPR — REFIT or redraw? A start to the discussion

    • Recap of the member state workshop on the evaluation of the BPR
    • Issues to reflect upon in the evaluation
    • Ideas from the field 
    Peter van Kampen Peter van Kampen
    Senior Policy Officer Biocides, Dutch Ministry of Infrastructure and Water Management

  26. Q&A and REFIT panel discussion with one or two suggestions from each participant

    • Harmonisation 
    • Implementation and simplification of the current BPR
    • Active substance approvals, product authorisations and renewal processes
    • The role of risk assesment 
    • Collaboration between the different stakeholders
    • Measures to foster innovation in the biocides sector 

  27. Networking drinks reception

    Join us for relaxed networking, drinks and appetizers with our speakers and attendees 

  28. Close of day one

View previous day

/ Next day
Back to top